PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Med Services Europe UAB

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Licensing Opportunity Available to Pharmaceutical Companies - Med Services Europe has announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals
Licensing Opportunity Available to Pharmaceutical Companies

 

NewswireToday - /newswire/ - Zurich, Switzerland, 2005/09/09 - Med Services Europe has announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Med Services Europe GmbH, a “Virtual European Headquarters” for Pharmaceutical and Medical Manufacturers, announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals.

Dr. Gene Emmer, President of Med Services Europe explained: “We have signed an agreement with a European-based pharmaceutical company that grants us the right to develop a network of distributors for an exciting portfolio of prescription pharmaceutical products. Our client will launch the portfolio in their home market. Med Services Europe will build and manage a network of pharmaceutical companies which will be responsible for marketing, sales and distribution of these products in their home markets. The products in the portfolio offer physicians options for handling Hormone Replacement Therapy (HRT).”

Dr. Emmer explained further about the opportunity that this portfolio presents to pharmaceutical companies “The media has sensationalized the recent findings of the Women’s Health Initiative (WHI) and there has been a strong over-reaction to the study’s findings. This has caused many competitors to abandon this market. However, most physicians agree that HRT is the only effective therapy for climacteric symptoms of menopause, commonly known as hot-flashes, or hot-flush, which can be extremely disabling for a large population of women. The market for HRT products is very large and growing due to ageing of the population and it is hungry for new launches. This portfolio offers many interesting advantages for the market and for the pharmaceutical companies that will represent them”

Dr Emmer encourages pharmaceutical companies to learn more about the opportunity to in-license this portfolio of products. “This is a unique opportunity to obtain marketing rights to an exciting portfolio of products, which are effective for a large and growing market. The media attention to WHI has served to decrease the competitive noise in this market and make this an exciting time for companies coming with a new message.”

Pharmaceutical companies interested in obtaining more information may contact Dr Emmer at Med Services Europe in Switzerland.

About Med Services Europe
Med Services Europe GmbH is located in Zurich Switzerland and specializes in Sales, Marketing and Business Development for Pharmaceutical and Medical manufacturers. Med Services acts as a virtual European Headquarters by developing and managing distribution networks for its clients.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Med Services Europe UAB

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Licensing Opportunity Available to Pharmaceutical Companies

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Dr. Gene Emmer - MedServicesEurope.com 
+41 764249963 info[.]medserviceseurope.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Med Services Europe UAB securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Med Services Europe UAB / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)